The short-term impact of copayment reductions for government subsidised medicines in Australia
{{output}}
Background: This study aims to examine the short-term, population-level effects of the 2023 Australian Pharmaceutical Benefits Scheme (PBS) copayment reduction on prescription volume, patients' out-of-pocket (OOP) expenditure, a... ...
